Literature DB >> 30100819

Formation of a protein corona influences the biological identity of nanomaterials.

Daniel Nierenberg1, Annette R Khaled1, Orielyz Flores1.   

Abstract

The development and testing of nanomaterials is an area of interest due to promising diagnostic and therapeutic applications in the treatment of diseases like cancer or cardiovascular disease. While extensive studies of the physicochemical properties of nanoparticles (NPs) are available, the investigation of the protein corona (PC) that is formed on NPs in biofluids is a relatively new area of research. The fact that few NPs are in clinical use indicates that the biological identity of NPs, which is in large part due to the PC formed in blood or other bodily fluids, may be altered in ways yet to be fully understood. Herein, we review the recent advances in PC research with the intent to highlight the current state of the field. We discuss the dynamic processes that control the formation of the PC on NPs, which involve the transient soft corona and more stable hard corona. Critical factors, like the environment and disease-state that affect the composition and stability of the PC are presented, with the intent of showcasing promising applications for utilizing the PC for disease diagnosis and the identification of disease-related biomarkers. This review summarizes the unique challenges presented by the nanoparticle corona and indicates future directions for investigation.

Entities:  

Keywords:  Cancer; Immunotoxicity; Lipids; Nanotechnology; Proteins

Year:  2018        PMID: 30100819      PMCID: PMC6084521          DOI: 10.1016/j.rpor.2018.05.005

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  68 in total

1.  Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.

Authors:  Debora Bonvin; Ulrich Aschauer; Duncan T L Alexander; Diego Chiappe; Marc Moniatte; Heinrich Hofmann; Marijana Mionić Ebersold
Journal:  Small       Date:  2017-06-05       Impact factor: 13.281

2.  An apolipoprotein-enriched biomolecular corona switches the cellular uptake mechanism and trafficking pathway of lipid nanoparticles.

Authors:  L Digiacomo; F Cardarelli; D Pozzi; S Palchetti; M A Digman; E Gratton; A L Capriotti; M Mahmoudi; G Caracciolo
Journal:  Nanoscale       Date:  2017-11-16       Impact factor: 7.790

3.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

4.  Disease-related metabolites affect protein-nanoparticle interactions.

Authors:  Mahdi Tavakol; Abbas Montazeri; Reza Naghdabadi; Mohammad J Hajipour; Saeid Zanganeh; Giulio Caracciolo; Morteza Mahmoudi
Journal:  Nanoscale       Date:  2018-04-19       Impact factor: 7.790

5.  Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation.

Authors:  Yang Li; Zhenzhen Shi; Isabella Radauer-Preiml; Ancuela Andosch; Eudald Casals; Ursula Luetz-Meindl; Macarena Cobaleda; Zhoumeng Lin; Majid Jaberi-Douraki; Paola Italiani; Jutta Horejs-Hoeck; Martin Himly; Nancy A Monteiro-Riviere; Albert Duschl; Victor F Puntes; Diana Boraschi
Journal:  Nanotoxicology       Date:  2017-12-01       Impact factor: 5.913

6.  Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum.

Authors:  Giulio Caracciolo; Luciano Callipo; Sofia Candeloro De Sanctis; Chiara Cavaliere; Daniela Pozzi; Aldo Laganà
Journal:  Biochim Biophys Acta       Date:  2009-11-14

7.  Smoking, COPD, and 3-nitrotyrosine levels of plasma proteins.

Authors:  Hongjun Jin; Bobbie-Jo Webb-Robertson; Elena S Peterson; Ruimin Tan; Diana J Bigelow; Mary Beth Scholand; John R Hoidal; Joel G Pounds; Richard C Zangar
Journal:  Environ Health Perspect       Date:  2011-06-06       Impact factor: 9.031

8.  The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.

Authors:  M W Lee; R Bassiouni; N A Sparrow; A Iketani; R J Boohaker; C Moskowitz; P Vishnubhotla; A S Khaled; J Oyer; A Copik; C Fernandez-Valle; J M Perez; A R Khaled
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

9.  Lipopolysaccharide Adsorbed to the Bio-Corona of TiO2 Nanoparticles Powerfully Activates Selected Pro-inflammatory Transduction Pathways.

Authors:  Massimiliano G Bianchi; Manfredi Allegri; Martina Chiu; Anna L Costa; Magda Blosi; Simona Ortelli; Ovidio Bussolati; Enrico Bergamaschi
Journal:  Front Immunol       Date:  2017-08-03       Impact factor: 7.561

10.  PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.

Authors:  Orielyz Flores; Santimukul Santra; Charalambos Kaittanis; Rania Bassiouni; Amr S Khaled; Annette R Khaled; Jan Grimm; J Manuel Perez
Journal:  Theranostics       Date:  2017-06-24       Impact factor: 11.556

View more
  16 in total

1.  Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.

Authors:  Chintan H Kapadia; Stephen A Ioele; Emily S Day
Journal:  J Biomed Mater Res A       Date:  2019-11-26       Impact factor: 4.396

Review 2.  Human Papillomavirus and the use of nanoparticles for immunotherapy in HPV-related cancer: A review.

Authors:  Michael Jakob Rupar; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2019-09-25

3.  Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum.

Authors:  Myolisi Ndumiso; Nela Buchtová; Lizex Husselmann; Gadija Mohamed; Ashwil Klein; Marique Aucamp; David Canevet; Sarah D'Souza; Retsepile E Maphasa; Frank Boury; Admire Dube
Journal:  Colloids Surf B Biointerfaces       Date:  2020-01-22       Impact factor: 5.268

4.  Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier Microvasculature.

Authors:  Sharon Wei Ling Lee; Marco Campisi; Tatsuya Osaki; Luca Possenti; Clara Mattu; Giulia Adriani; Roger Dale Kamm; Valeria Chiono
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

Review 5.  Analysing the nanoparticle-protein corona for potential molecular target identification.

Authors:  Chandra Kumar Elechalawar; Md Nazir Hossen; Lacey McNally; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  J Control Release       Date:  2020-03-09       Impact factor: 9.776

6.  Multivariate modeling of engineered nanomaterial features associated with developmental toxicity.

Authors:  Kimberly T To; Lisa Truong; Sabrina Edwards; Robert L Tanguay; David M Reif
Journal:  NanoImpact       Date:  2019-11-01

7.  High Surface Reactivity and Biocompatibility of Y2O3 NPs in Human MCF-7 Epithelial and HT-1080 FibroBlast Cells.

Authors:  Mohd Javed Akhtar; Maqusood Ahamed; Salman A Alrokayan; Muthumareeswaran M Ramamoorthy; ZabnAllah M Alaizeri
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

Review 8.  Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.

Authors:  Sabina Halappanavar; Sybille van den Brule; Penny Nymark; Laurent Gaté; Carole Seidel; Sarah Valentino; Vadim Zhernovkov; Pernille Høgh Danielsen; Andrea De Vizcaya; Henrik Wolff; Tobias Stöger; Andrey Boyadziev; Sarah Søs Poulsen; Jorid Birkelund Sørli; Ulla Vogel
Journal:  Part Fibre Toxicol       Date:  2020-05-25       Impact factor: 9.400

Review 9.  MicroRNA delivery through nanoparticles.

Authors:  Sharon Wei Ling Lee; Camilla Paoletti; Marco Campisi; Tatsuya Osaki; Giulia Adriani; Roger D Kamm; Clara Mattu; Valeria Chiono
Journal:  J Control Release       Date:  2019-10-14       Impact factor: 9.776

10.  Gemini Cationic Lipid-Type Nanovectors Suitable for the Transfection of Therapeutic Plasmid DNA Encoding for Pro-Inflammatory Cytokine Interleukin-12.

Authors:  Natalia Sánchez-Arribas; María Martínez-Negro; Clara Aicart-Ramos; Conchita Tros de Ilarduya; Emilio Aicart; Andrés Guerrero-Martínez; Elena Junquera
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.